Atlas Trials

Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases

Clinical trial NCT03590119 · COMPLETED

Trial details

NCT number
NCT03590119
Sponsor
Marnix Lam
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Neuroendocrine TumorsLiver Metastases
Start date
2018-08-01
Primary completion
2022-09-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.